Skip to main content
. 2020 Jan 31;29:105206. doi: 10.1016/j.dib.2020.105206

Fig. 2.

Fig. 2

CYP450 liability of new thyromimetics. % Inhibition of five CYP450 enzymes (CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4). See Table 1 for further details.